Tech Company Financing Transactions
Day Zero Diagnostics Funding Round
On 1/29/2019, Day Zero Diagnostics raised $8.6 million in Series A investment from TriVentures II Fund, Golden Seeds and Sands Capital Management.
Transaction Overview
Company Name
Announced On
1/29/2019
Transaction Type
Venture Equity
Amount
$8,600,000
Round
Series A
Investors
Proceeds Purpose
This funding allows us to continue our diagnostic system development effort and to expand our R&D program to additional use cases in infectious disease where speed and precision matter.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Boston, MA 02134
USA
Phone
Website
Email Address
Overview
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jong Lee
Chief Technical Officer
Miriam Huntley
Co-Founder
Melis Anahtar
Co-Founder
Douglas Kwon
Co-Founder
Dougal Maclaurin
Browse more venture capital transactions:
Prev: 1/29/2019: Mosyle venture capital transaction
Next: 1/29/2019: ContentSquare venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs